Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present InflaRx N.V. (NASDAQ: IFRX).

Full DD Report for IFRX

You must become a subscriber to view this report.

Recent News from (NASDAQ: IFRX)

InflaRx N.V. To Host R&D Day on Hidradenitis Suppurativa and its Breakthrough Anti-C5a Monoclonal Antibody IFX-1
Live webcast on Friday, September 7, 2018, 7.45-9.30 am EDT (1.45-3.30 pm CET) JENA, Germany, Aug. 28, 2018 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq:IFRX), a biopharmaceutical company developing innovative therapeutics to treat life-threatening and devastating inflammatory diseases ...
Source: GlobeNewswire
Date: August, 28 2018 07:30
InflaRx reports Q2 results
InflaRx (NASDAQ: IFRX ): Q2 EPS of -€0.10 More news on: InflaRx N.V., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: August, 09 2018 07:11
InflaRx N.V. Reports Second Quarter 2018 Financial & Operating Results
Received FDA clearance of IND for Phase II trial of IFX-1 in ANCA-associated vasculitis Established U.S. research facility to continue advancing complement-based research Completion of follow-on offering raising $62.9 million in primary proceeds Cash position approximately Ȋ...
Source: GlobeNewswire
Date: August, 09 2018 07:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IFRX.

About InflaRx N.V. (NASDAQ: IFRX)

Logo for InflaRx N.V. (NASDAQ: IFRX)

Not available


Contact Information



    Current Share Structure


      Daily Technical Chart for (NASDAQ: IFRX)

      Daily Technical Chart for (NASDAQ: IFRX)

      Stay tuned for daily updates and more on (NASDAQ: IFRX)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: IFRX)

      Do your DD and if you choose, be ready to go!


      The Research: All source information contained in this email is from the public sources mentioned below.



      Thank you

      DD Report



      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IFRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IFRX and does not buy, sell, or trade any shares of IFRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: